Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 25 EP applications Maria Garcia Prieto has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710928

NOVEL SUBSTITUTED TRIAZOLYL PIPERAZINE AND TRIAZOLYL PIPERIDINE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/4196, C07D 249/10
Applicant:
Cellzome Ltd
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12717280

SALT OF AN INHIBITOR OF PHOSPHODIESTERASE 10 ENZYME

IPC classification:
A61K 31/4985, C07D 487/04, A61P 25/18
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12729637

1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES

IPC classification:
A61K 31/4985, C07D 487/04, A61P 25/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12733754

NOVEL SUBSTITUTED INDOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/5383, C07D 498/04, C07D 487/04, A61P 25/28
Applicant:
Cellzome Ltd
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13730364

SUBSTITUTED 3, 4 - DIHYDRO - 2H - PYRIDO [1, 2 -A]PYRAZINE - 1, 6 - DIONE DERIVATIVES USEFUL FOR THE TREATMENT OF (INTER ALIA) ALZHEIMER'S DISEASE

IPC classification:
A61K 31/5513, C07D 471/04, A61P 25/28
Applicant:
Cellzome Ltd
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13731752

COMBINATIONS COMPRISING PDE 2 INHIBITORS SUCH AS 1-ARYL-4-METHYL- [1,2,4]TRIAZOLO [4,3-A]QUINOXALINE COMPOUNDS AND PDE 10 INHIBITORS FOR USE IN THE TREATMENT OF NEUROLOGICAL OR METABOLIC DISORDERS

IPC classification:
A61K 45/06, A61K 31/5377, A61K 31/517, A61K 31/4725, A61K 31/472, A61K 31/4709, A61P 21/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP13736868

INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME

IPC classification:
A61K 31/502, A61K 31/4985, C07D 487/04, A61P 25/00, A61P 3/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14724109

SULPHAMOYLTHIOPHENAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
C07D 409/12, C07D 333/34
Applicant:
Janssen Sciences Ireland UC
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14727824

6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61P 25/00, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14729373

4-AMINO-6-PHENYL-6,7-DIHYDRO[1,2,3]TRIAZOLO[1,5-A]PYRAZINE DERIVATIVES AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61P 25/28, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14732131

4-AMINO-6-PHENYL-5,6-DIHYDROIMIDAZO[1,5-A]PYRAZIN-3(2H)-ONE DERIVATIVES AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61P 25/28, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14729896

4-AMINO-6-PHENYL-5,6-DIHYDROIMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61P 25/28, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14758564

1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 31/437, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP14793047

CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
C07D 405/12, A61K 31/40, A61K 31/445, A61P 31/20, C07D 209/16, C07D 207/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP13898358

CRYSTAL FORM OF NUCLEOSIDE INHIBITOR OF HCV

IPC classification:
A61P 31/14, A61K 31/7072, C07H 19/11
Applicant:
Janssen Sciences Ireland UC
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15700726

COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE

IPC classification:
A61P 25/06, A61P 25/08, A61P 25/00, A61K 31/4015, A61K 9/48, A61K 31/437, A61K 31/506, A61K 31/4545, A61K 31/381, A61K 31/496, A61K 45/06
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15750666

6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61P 25/00, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15744915

6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61P 25/00, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP15742317

6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61P 25/00, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Grant of patent is intended
EP15744568

6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61P 25/00, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Grant of patent is intended
EP15747422

6,7-DIHYDROPYRAZOLO[1,5- ]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU2 RECEPTORS

IPC classification:
A61P 25/00, A61K 31/4985, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16770283

2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES

IPC classification:
A61P 25/28, A61P 25/16, A61K 31/4418, C07D 401/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16793800

[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-7-YL COMPOUND

IPC classification:
A61P 25/18, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16822655

RADIOLABELLED MGLUR2/3 PET LIGANDS

IPC classification:
A61K 101/02, C07D 487/04, C07B 59/00, A61K 51/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16812961

RADIOLABELLED MGLUR2/3 PET LIGANDS

IPC classification:
A61K 101/02, C07D 487/04, C07B 59/00, A61K 51/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Maria Garcia Prieto, Janssen Pharmaceutica N.V.
Status:
Request for examination was made

Please Sign in to use this feature